Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
NCT05730699
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuromyelitis Optica Spectrum Disorders
Interventions
BIOLOGICAL:
divozilimab
Sponsor
Biocad